Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Replication fork stability confers chemoresistance in BRCA-deficient cells
Arnab Ray Chaudhuri, Elsa Callén, Xia Ding, et al.
Nature (2016) Vol. 535, Iss. 7612, pp. 382-387
Open Access | Times Cited: 831

Showing 1-25 of 831 citing articles:

PARP inhibitors: Synthetic lethality in the clinic
Christopher J. Lord, Alan Ashworth
Science (2017) Vol. 355, Iss. 6330, pp. 1152-1158
Open Access | Times Cited: 2333
The multifaceted roles of PARP1 in DNA repair and chromatin remodelling
Arnab Ray Chaudhuri, André Nussenzweig
Nature Reviews Molecular Cell Biology (2017) Vol. 18, Iss. 10, pp. 610-621
Open Access | Times Cited: 1366
Endogenous DNA Damage as a Source of Genomic Instability in Cancer
Anthony Tubbs, André Nussenzweig
Cell (2017) Vol. 168, Iss. 4, pp. 644-656
Open Access | Times Cited: 1208
State-of-the-art strategies for targeting the DNA damage response in cancer
Patrick G. Pilié, Chad Tang, Gordon B. Mills, et al.
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 2, pp. 81-104
Open Access | Times Cited: 967
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas
Theo Knijnenburg, Linghua Wang, Michael T. Zimmermann, et al.
Cell Reports (2018) Vol. 23, Iss. 1, pp. 239-254.e6
Open Access | Times Cited: 952
The rediscovery of platinum-based cancer therapy
Sven Rottenberg, Carmen A. Widmer, Paola Perego
Nature reviews. Cancer (2020) Vol. 21, Iss. 1, pp. 37-50
Closed Access | Times Cited: 688
A decade of clinical development of PARP inhibitors in perspective
Joaquı́n Mateo, Christopher J. Lord, Violeta Serra, et al.
Annals of Oncology (2019) Vol. 30, Iss. 9, pp. 1437-1447
Open Access | Times Cited: 568
PARP and PARG inhibitors in cancer treatment
Dea Slade
Genes & Development (2020) Vol. 34, Iss. 5-6, pp. 360-394
Open Access | Times Cited: 525
PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
Maddison Rose, Joshua T. Burgess, Kenneth J. O’Byrne, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 515
Mechanisms of PARP inhibitor sensitivity and resistance
Alan D. D’Andrea
DNA repair (2018) Vol. 71, pp. 172-176
Open Access | Times Cited: 418
Poly(ADP-ribose) polymerase inhibition: past, present and future
Nicola J. Curtin, Csaba Szabó
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 10, pp. 711-736
Closed Access | Times Cited: 407
SAMHD1 acts at stalled replication forks to prevent interferon induction
Flavie Coquel, Maria João Silva, Hervé Técher, et al.
Nature (2018) Vol. 557, Iss. 7703, pp. 57-61
Open Access | Times Cited: 385
MRE11 and EXO1 nucleases degrade reversed forks and elicit MUS81-dependent fork rescue in BRCA2-deficient cells
Delphine Lemaçon, Jessica Jackson, Annabel Quinet, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 378
Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids
Sarah J. Hill, Brennan Decker, Emma A. Roberts, et al.
Cancer Discovery (2018) Vol. 8, Iss. 11, pp. 1404-1421
Open Access | Times Cited: 374
PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells
Sylvie M. Noordermeer, Haico van Attikum
Trends in Cell Biology (2019) Vol. 29, Iss. 10, pp. 820-834
Open Access | Times Cited: 374
Restoration of Replication Fork Stability in BRCA1- and BRCA2-Deficient Cells by Inactivation of SNF2-Family Fork Remodelers
Angelo Taglialatela, Silvia Álvarez, Giuseppe Leuzzi, et al.
Molecular Cell (2017) Vol. 68, Iss. 2, pp. 414-430.e8
Open Access | Times Cited: 363
The MRE11–RAD50–NBS1 Complex Conducts the Orchestration of Damage Signaling and Outcomes to Stress in DNA Replication and Repair
Aleem Syed, John A. Tainer
Annual Review of Biochemistry (2018) Vol. 87, Iss. 1, pp. 263-294
Open Access | Times Cited: 359
Understanding and overcoming resistance to PARP inhibitors in cancer therapy
Mariana Paes Dias, Sarah C. Moser, Shridar Ganesan, et al.
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 12, pp. 773-791
Closed Access | Times Cited: 359
PARP inhibitor resistance: the underlying mechanisms and clinical implications
He Li, Zhaoyi Liu, Nayiyuan Wu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 355
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer
Cristina Cruz, Marta Castroviejo‐Bermejo, Sara Gutiérrez‐Enríquez, et al.
Annals of Oncology (2018) Vol. 29, Iss. 5, pp. 1203-1210
Open Access | Times Cited: 353
ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells
Stephanie A. Yazinski, Valentine Comaills, Rémi Buisson, et al.
Genes & Development (2017) Vol. 31, Iss. 3, pp. 318-332
Open Access | Times Cited: 348
Mechanisms of Oncogene-Induced Replication Stress: Jigsaw Falling into Place
Panagiotis Kotsantis, Eva Petermann, Simon J. Boulton
Cancer Discovery (2018) Vol. 8, Iss. 5, pp. 537-555
Open Access | Times Cited: 343
Smarcal1-Mediated Fork Reversal Triggers Mre11-Dependent Degradation of Nascent DNA in the Absence of Brca2 and Stable Rad51 Nucleofilaments
Arun Mouli Kolinjivadi, Vincenzo Sannino, Anna De Antoni, et al.
Molecular Cell (2017) Vol. 67, Iss. 5, pp. 867-881.e7
Open Access | Times Cited: 341
Replication fork reversal triggers fork degradation in BRCA2-defective cells
Sofija Mijic, Ralph Zellweger, Nagaraja Chappidi, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 338
The Fanconi Anemia Pathway in Cancer
Niraj Joshi, Anniina Färkkilä, Alan D. D’Andrea
Annual Review of Cancer Biology (2018) Vol. 3, Iss. 1, pp. 457-478
Open Access | Times Cited: 331
Page 1 - Next Page

Scroll to top